Strategic Alliances
Compound Partnering
PPD's compound partnering business is now Furiex Pharmaceuticals, Inc., an independent, publicly traded company.
PPD's compound partnering business is now Furiex Pharmaceuticals, Inc., an independent, publicly traded company.
Collaboration with Merck
Our strategic collaboration with Merck enabled us to acquire its vaccines and biologics infrastructure, broaden our therapeutic expertise and expand our existing relationship.
Our strategic collaboration with Merck enabled us to acquire its vaccines and biologics infrastructure, broaden our therapeutic expertise and expand our existing relationship.
Alliance with WHISCON
We have expanded our post-approval safety expertise and risk management through an alliance with World Health Information Science Consultants.
We have expanded our post-approval safety expertise and risk management through an alliance with World Health Information Science Consultants.
Partnership with PUL
To meet growing client demand in Southeast Asia, we partnered with Peking Union Lawke Biomedical Development Limited (PUL) to establish our central lab services in China.
To meet growing client demand in Southeast Asia, we partnered with Peking Union Lawke Biomedical Development Limited (PUL) to establish our central lab services in China.
Our e-Newsletter is your source for what is happening at PPD and in the CRO industry.
